FR2106566A1 - Tabletting active materials - by compressing encapsulated particles - Google Patents
Tabletting active materials - by compressing encapsulated particlesInfo
- Publication number
- FR2106566A1 FR2106566A1 FR7133428A FR7133428A FR2106566A1 FR 2106566 A1 FR2106566 A1 FR 2106566A1 FR 7133428 A FR7133428 A FR 7133428A FR 7133428 A FR7133428 A FR 7133428A FR 2106566 A1 FR2106566 A1 FR 2106566A1
- Authority
- FR
- France
- Prior art keywords
- tabletting
- compressing
- active materials
- encapsulated particles
- encapsulated
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
- A61K33/26—Iron; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/28—Compounds containing heavy metals
- A61K31/295—Iron group metal compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/365—Lactones
- A61K31/375—Ascorbic acid, i.e. vitamin C; Salts thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
- A61K31/51—Thiamines, e.g. vitamin B1
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
- A61K31/525—Isoalloxazines, e.g. riboflavins, vitamin B2
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1682—Processes
- A61K9/1694—Processes resulting in granules or microspheres of the matrix type containing more than 5% of excipient
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2095—Tabletting processes; Dosage units made by direct compression of powders or specially processed granules, by eliminating solvents, by melt-extrusion, by injection molding, by 3D printing
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5089—Processes
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J2/00—Processes or devices for granulating materials, e.g. fertilisers in general; Rendering particulate materials free flowing in general, e.g. making them hydrophobic
- B01J2/006—Coating of the granules without description of the process or the device by which the granules are obtained
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Inorganic Chemistry (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US7285670A | 1970-09-16 | 1970-09-16 |
Publications (2)
Publication Number | Publication Date |
---|---|
FR2106566A1 true FR2106566A1 (en) | 1972-05-05 |
FR2106566B1 FR2106566B1 (zh) | 1975-04-18 |
Family
ID=22110165
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
FR7133428A Granted FR2106566A1 (en) | 1970-09-16 | 1971-09-16 | Tabletting active materials - by compressing encapsulated particles |
Country Status (4)
Country | Link |
---|---|
AU (1) | AU3317871A (zh) |
DE (1) | DE2146174A1 (zh) |
FR (1) | FR2106566A1 (zh) |
NL (1) | NL7112083A (zh) |
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2185390A1 (zh) * | 1972-05-19 | 1974-01-04 | Beecham Group Ltd | |
FR2200006A1 (zh) * | 1972-09-25 | 1974-04-19 | Warner Lambert Co | |
DE2509572A1 (de) * | 1974-03-08 | 1975-09-11 | Beecham Group Ltd | Trockenpraeparat und feine partikel |
US3907983A (en) * | 1973-02-16 | 1975-09-23 | Hoffmann La Roche | Pharmaceutical preparations |
FR2385388A1 (zh) * | 1977-04-01 | 1978-10-27 | Hoechst Ag |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4173626A (en) | 1978-12-11 | 1979-11-06 | Merck & Co., Inc. | Sustained release indomethacin |
GB2075458B (en) * | 1980-04-21 | 1983-06-02 | Nicholas Pty Ltd | Encapsulation of indomethacin |
DE4119306C2 (de) * | 1991-06-12 | 1996-05-30 | Wheli Inter Ag | Organische Rohstoffe, Zwischen- und Endprodukte für die Ernährung und zur Verwendung für technische Zwecke, die Vitalstoffe enthalten |
IE940292A1 (en) * | 1994-04-06 | 1995-10-18 | Elan Corp Plc | Biodegradable microcapsules and method for their manufacture |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3488418A (en) * | 1965-11-18 | 1970-01-06 | Sterling Drug Inc | Sustained relief analgesic composition |
US3524910A (en) * | 1965-11-18 | 1970-08-18 | Sterling Drug Inc | Sustained relief analgesic compositions |
US3557279A (en) * | 1969-06-12 | 1971-01-19 | Merck & Co Inc | Microencapsulation form of an anti-inflammatory drug |
-
1971
- 1971-09-02 NL NL7112083A patent/NL7112083A/xx unknown
- 1971-09-07 AU AU33178/71A patent/AU3317871A/en not_active Expired
- 1971-09-15 DE DE19712146174 patent/DE2146174A1/de active Pending
- 1971-09-16 FR FR7133428A patent/FR2106566A1/fr active Granted
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3488418A (en) * | 1965-11-18 | 1970-01-06 | Sterling Drug Inc | Sustained relief analgesic composition |
US3524910A (en) * | 1965-11-18 | 1970-08-18 | Sterling Drug Inc | Sustained relief analgesic compositions |
US3557279A (en) * | 1969-06-12 | 1971-01-19 | Merck & Co Inc | Microencapsulation form of an anti-inflammatory drug |
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2185390A1 (zh) * | 1972-05-19 | 1974-01-04 | Beecham Group Ltd | |
FR2200006A1 (zh) * | 1972-09-25 | 1974-04-19 | Warner Lambert Co | |
US3907983A (en) * | 1973-02-16 | 1975-09-23 | Hoffmann La Roche | Pharmaceutical preparations |
DE2509572A1 (de) * | 1974-03-08 | 1975-09-11 | Beecham Group Ltd | Trockenpraeparat und feine partikel |
FR2385388A1 (zh) * | 1977-04-01 | 1978-10-27 | Hoechst Ag |
Also Published As
Publication number | Publication date |
---|---|
DE2146174A1 (de) | 1972-03-30 |
FR2106566B1 (zh) | 1975-04-18 |
NL7112083A (zh) | 1972-03-20 |
AU3317871A (en) | 1973-03-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE3688674D1 (de) | Hydroxypropylcelluloseether enthaltende mittel mit verzoegerter wirkstoffabgabe. | |
AU584674B2 (en) | Quick-liquifying chewable tablet | |
IL71558A (en) | Divisible tablet with delayed release of active substance and its production | |
EP0096286A3 (de) | Hydrolyseempfindlichen Wirkstoff enthaltende, lagerstabile Tablette | |
FR2106566A1 (en) | Tabletting active materials - by compressing encapsulated particles | |
AU2793989A (en) | Method for preparing a solid sustained release form of a functionally active composition and the dosage form so obtained | |
AU476438B2 (en) | 4-biphenylyl alcohols and pharmaceutical compositions containing them | |
IL35848A (en) | Effervescent tablets and powders and process for the preparation thereof | |
AU544975B2 (en) | Oxazole derivatives | |
GB1327560A (en) | Effervescent pharmaceutical preparations | |
CA992079A (en) | Optically active 1,4-benzodiazepines and process for the preparation thereof | |
CA1023762A (en) | Halocyclopropyl substituted phenoxyalkanoic acids and esters | |
CA983391A (en) | Pharmaceutical composition containing sulfapyridazines, bismuth subcarbonate or subnitrate and ethylcellulose | |
CA994243A (en) | Sterilized glyceryl guaiacolate powder and process for manufacturing same | |
CA945544A (en) | 16-METHYLENE-9.beta., 10.alpha.-STEROID COMPOUNDS, PHARMACEUTICAL PREPARATIONS WHICH CONTAIN THE NOVEL COMPOUNDS AS ACTIVE INGREDIENTS, AND METHODS OF PRODUCING THE SAID COMPOUNDSAND PREPARATIONS | |
CA931953A (en) | 2,(2',6'-dichlorophenyl)1,3-thiazine-4-one, methods of producing the said substance and preparations containing it as an active ingredient | |
CA839226A (en) | Biologically active particulate material and the process for manufacturing same | |
KR790000794B1 (en) | Process for preparing solid medicament | |
NL169467B (nl) | Werkwijze voor het bereiden of vervaardigen van een geneesmiddel met een vitamine a-activiteit ten aanzien van dde genezing van wonden, alsmede voor het bereiden van daarvoor geschikte 2,6,6-trimethyl-1-carboxyalkapolyenyl-cylohexeen-1-verbindingen. | |
GB1454872A (en) | Anticonvulsant | |
CA1003428A (en) | 3-hydroxy-1-sulphones, their preparation and use in the preparation of alcohols | |
CA909211A (en) | Amphoteric cellulose and process for the preparation thereof | |
CA859700A (en) | Pharmaceutical preparation and process for the manufacture thereof | |
CA819719A (en) | 17.beta.-HALO-16.alpha.-(2-OXOALKYL)-17-ISOPREGNANES AND PREPARATION THEREOF | |
CA914152A (en) | 9.alpha.-FLUORO-16-FLUOROMETHYLENEPREDNISOLONE-21-ENANTHATE AND PROCESS FOR THE PREPARATION THEREOF |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
ST | Notification of lapse |